Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05953051

Tunnel Widening in Augmented ACL Integration Via PrP Enriched Collected Autologous Bone vs Standard ACL Technique

The purpose of this clinical study is to compare the outcomes of two surgical techniques for reconstruction of the anterior cruciate ligament (ACL) after a single, primary ACL rupture.

The main question to be answered is:

- Does less widening of the tibial tunnel occur when a bone/Platelet rich plasma (PrP) composite material is placed directly into the tibial tunnel after fixation of the implant (experimental group) compared to the same surgery without the use of the composite material (control group)?

Participants will be randomized into one of the two groups and they will not know which group they belong to. After 12 months they will undergo CT, MRI, medical examination and functional knee testing. They will have a further medical examination and functional knee testing at 24 months. Patient Reported Outcomes will be collected before surgery, 6, 12 and 24 months after surgery.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

About this study

To be successful, an ACL reconstruction requires a strong incorporation of the tendon to the bone within or at the margin of the tunnel, but the tunnel itself is at risk of widening, therefore compromising the tendon attachment. A composite of harvested healthy autologous bone fragments from the tunnel and autologous thrombin and fibrin, generated from the patient's PrP could be used at the interface between tunnel and ACL graft at the tibia and femur to reduce frequency of tunnel widening and therefore improve graft-bone-integration.

The study seeks primarily to determine less tibial tunnel widening when a bone/PrP-composite is applied directly in the tibial tunnel compared to the same surgery without using the composite, measured with CT and MRI.

Secondary study objectives are to evaluate femoral tunnel widening, tibial and femoral graft incorporation, graft maturation and knee function (clinical, functional, patient reported) over the course of 24 months follow-up and to evaluate occurrence of procedure- and product-related adverse events and complications.

This is a prospective, single-center, single-blinded, 2-arm-parallel, randomized, controlled study with 24 months follow-up. Participants will be recruited from the Knee Surgery department at Schulthess Klinik when scheduled for ACL reconstruction. The study sample comprises 107 patients, allocated 1:1 on experimental and control arm. Outcome measures are taken at 0, 6, 12, and 24 months. The total study duration is 48 months. The study duration per patient is 24 months.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18-50 years
  • Primary ACL rupture
  • Time from injury to surgery: 4 weeks to 6 months
  • Single ACL rupture (isolated rupture)
  • ACL surgery with one of the participating senior surgeons
  • Informed Consent as documented by signature

Exclusion criteria

  • Concomitant ligamentous instability/rupture
  • Requirement for Meniscus suture (partial resection accepted, hoop and roots remain intact)
  • Requirement for cartilage invasive treatment (debridement accepted)
  • Osteoarthritis at index knee joint
  • Leg axis deviation over 3° valgus or 4° varus
  • Claustrophobia (contra-indication for the MRI)
  • Women who are pregnant or breast feeding or intention to become pregnant during the study
  • Known or suspected non-compliance, drug or alcohol abuse
  • Inability of the patient to follow the study procedures, e.g. language problems, psychological disorders, dementia, etc.

Treatment and study plan

ACL reconstruction with bone/PrP-composite

Procedure

During standard ACL reconstruction, the drilled bone debris is collected in a sterile filtered chamber.

Then the bone debris is mixed with PrP. After fixation of the graft the composite is inserted into the drilled tunnel at the interface between tendon to bone. The intraarticular aperture sites are sealed by use of fibrin that is previously gathered out of the PrP as well.

ACL reconstruction (Standard)

Procedure

Standard ACL reconstruction with Semitendinosus alone or plus gracilis, femoral fixation via extracortical fixation by adjustable loop device, tibial fixation via a bio-interference screw or adjustable device

Primary outcomes

  1. Tibial tunnel diameter change

    Time frame: 10 to 14 months post-surgery

    Diameter (mm) change of tibial tunnel in relation to tunnel diameter reported from surgery; assessed by one radiologist (CT); CT scanning is performed from a level just above the femoral external foramen to a level below the outer hole of the tibial tunnel in order to visualise the positioning of the autograft-fixing metallic devices. The scan is aligned so that the tunnel axis is in the sagittal plane. The diameter of the headed reamer that drilled the tibial tunnel is defined as the baseline diameter of the tibial tunnel (D0). Measurements are taken at 4 different levels for the tibial tunnels using 3D Multiplanar reconstruction. All diameters are calculated in mm within the measurement function of the picture archiving system. The percentage of widening is defined as the difference between initial drilling diameter D0 (derived from surgery report) and post-op measurements D12 in relation to initial drilling diameter D0.

  2. Tibial tunnel volume change

    Time frame: 10 to 14 months post-surgery

    Volume (mm^3) change of tibial tunnel in relation to tunnel volume reported from surgery; assessed by one radiologist (CT); the border of the bone tunnel is drawn manually on every fourth slice in both the coronal plane and the sagittal plane and interpolated automatically in between. Based on the contours in those two planes, the contours in the axial plane are interpolated automatically into a 3D mask. The volume of the bone tunnel is determined by automatic voxel counting^.

Secondary outcomes

  1. Femoral tunnel diameter change

    Time frame: 10 to 14 months post-surgery

    Diameter (mm) change of femoral tunnel in relation to tunnel diameter reported from surgery; assessed by one radiologist (CT); CT scanning is performed from a level just above the femoral external foramen to a level below the outer hole of the tibial tunnel in order to visualise the positioning of the autograft-fixing metallic devices. The scan is aligned so that the tunnel axis is in the sagittal plane. The diameter of the headed reamer that drilled the femoral tunnel is defined as the baseline diameter of the femoral tunnel (D0). Measurements are taken at 4 different levels for the femoral tunnels using 3D Multiplanar reconstruction. All diameters are calculated in mm within the measurement function of the picture archiving system. The percentage of widening is defined as the difference between initial drilling diameter D0 (derived from surgery report) and post-op measurements D12 in relation to initial drilling diameter D0.

  2. Femoral tunnel volume change

    Time frame: 10 to 14 months post-surgery

    Volume (mm^3) change of femoral tunnel in relation to tunnel volume reported from surgery; assessed by one radiologist (CT); the border of the bone tunnel is drawn manually on every fourth slice in both the coronal plane and the sagittal plane and interpolated automatically in between. Based on the contours in those two planes, the contours in the axial plane are interpolated automatically into a 3D mask. The volume of the bone tunnel is determined by automatic voxel counting.

  3. Graft maturity_subj

    Time frame: 10 to 14 months post-surgery

    tibial & femoral, subjectively, using a 4-grade system MRI after 12 months based on Proton-density-weighted images

    • Grade 1 signal ("normal"): when the entire segment of graft has a homogeneous, low intensity signal indistinguishable from that of the posterior cruciate ligament
    • Grade 2: if the segment of graft retained at least 50% of "normal" ligament signal intermixed with portions of the graft that had become edematous, as indicated by areas of increased signal intensity
    • Grade 3: when a segment of graft had ~50% of its area exhibiting a normal appearing ligament signal
    • Grade 4: diffuse increase in signal intensity with no normal-looking strands of ligament (100% oedematous).
  4. Graft maturity_obj

    Time frame: 10 to 14 months post-surgery

    objectively, within the tibial and femoral tunnels and in the intra-articular portion using the mean intensity of a region of interest on MRI to estimate the graft signal to noise quotient (SNQ) in comparison to the quadriceps tendon: SNQ = Signal intensity graft - Signal intensity quadriceps tendon / SI background

  5. Graft integration

    Time frame: 10 to 14 months post-surgery

    tibial & femoral,

    • Grade I, full attachment of a low-intensity signal band onto the bone tunnel with no fibrous tissue at the tendon-bone interface;
    • Grade II, a low-intensity signal band with a partial high- intensity signal band at the tendon-bone interface;
    • Grade III, the graft bone interface is filled with a continuous high- intensity signal band.
  6. Bone healing and integration

    Time frame: 10 to 14 months post-surgery

    subjectively, tibial & femoral, of the applied autologous bone matrix

    • Grade I, excellent integration indicating no space between the graft and osseous formation in the proximal and mid portion.
    • Grade II, good integration indicating no space between the graft and osseous formation in the proximal or mid portion.
    • Grade III, fair integration indicating a gap between the graft and osseous formation in the proximal and mid portion.
    • Grade IV, poor integration indicating no osseous formation in the proximal and mid portion.

Other outcomes

  1. Range of motion

    Time frame: 10-14 and 20-28 months post-surgery

    extension and flexion (°) both knees

  2. Isokinetic knee strength test

    Time frame: 10-14 and 20-28 months post-surgery

    Extension and Flexion (Nm), operated vs. non-operated side

  3. Y-balance test

    Time frame: 10-14 and 20-28 months post-surgery

    balance on one leg whilst simultaneously reaching as far as possible with the other leg in three separate directions: anterior, posterolateral, and posteromedial

  4. Knee Laxity

    Time frame: 10-14 and 20-28 months post-surgery

    the patient is placed in the supine position on an examination table, the knees remain at approximately 30° of flexion and the tibia a 15° rotation. The displacement is consequently measured with the KT-1000 arthrometer device, calculating the relative motion between the sensor pad on the patella and the sensor pad on the anterior tibia under 67, 89 and 134 N force. The healthy leg is always to be tested first followed by the injured leg. The side-to-side differences are then evaluated at each force (mm)

  5. Front hop

    Time frame: 10-14 and 20-28 months post-surgery

    unilateral forward jump as far as possible (cm)

  6. Side hop

    Time frame: 10-14 and 20-28 months post-surgery

    repeated side hops over a distance of 40 cm and back to start position (number of touch-downs within 30 seconds)

  7. gait restrictions

    Time frame: 10-14 and 20-28 months post-surgery

    gait restrictions related to the operated knee (i.e. limping) (y/n)

  8. adverse events

    Time frame: 10-14 and 20-28 months post-surgery

    procedure- and product-related adverse events will be described and given as frequency per type

  9. European Quality of Life 5 Dimensions 5 Level Version (EQ-5D-5L)

    Time frame: -3 to 0, 6, 12, 24 months post-surgery

    standardized instrument for measuring generic health status regardless of existing diseases within five dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression), result is a 5-level health state

  10. EuroQol visual analogue scale (EQ-VAS)

    Time frame: -3 to 0, 6, 12, 24 months post-surgery

    Quality of life, regardless of existing diseases, visual analogue scale from 0 - 100. 0 points correspond to the worst possible health status, while 100 points correspond to the best possible health status.

  11. Knee Injury and Osteoarthritis Outcome Score (KOOS)

    Time frame: -3 to 0, 6, 12, 24 months post-surgery

    assess patient-relevant outcomes following knee injury using 42 items within 5 subscales, which are scored separately; each of the five scores is calculated as the sum of the items included. Scores are transformed to a 0-100 scale, with zero representing extreme knee problems and 100 representing no knee problems.

  12. Tegner Activity Scale

    Time frame: 12, 24 months post-surgery

    one-item score that grades activity based on work and sports activities on a scale of 0 (disability because of knee problems) to 10 (national or international elite level)

  13. Return to Sport Injury Scale (ACL-RSI)

    Time frame: 12, 24 months post-surgery

    the patient's self-confidence and risk assessment regarding a return to sport after ACL reconstruction with 12 items using a numeric rating scale of 0 to 100.

  14. Numeric Rating scale for pain (NRS) in the knee

    Time frame: -3 to 0, 6, 12, 24 months post-surgery

    unidimensional measure of pain intensity in adults, where 0=no pain and 10=worst possible pain

Study contacts

Contact information is provided by the study sponsor or research team.

Anika Stephan, MA

CONTACT

[email protected]

+41 44 385 ext. 79 84

Vincent A Stadelmann, PhD

CONTACT

[email protected]

+41 44 385 ext. 75 87

Sponsors and collaborators

Lead sponsor

Schulthess Klinik

Other

Registry information

Official study title

A Single-center, Patient-blinded, Randomized, 2-year, Parallel-group, Superiority Study to Compare the Efficacy of Augmented ACL Integration Via Platelet-rich-plasma Enriched Collected Autologous Bone Versus Standard ACL Technique

Important dates

Study start
2024
Primary completion
2026
Study completion
2027
First posted
Jul 19, 2023
Registry last updated
Jan 29, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.